Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics

SAN DIEGO, July 03, 2018 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation for ... Biopharmaceuticals, Oncology, Drug Delivery, Acquisitions Sorrento Therapeutics, Kimberly-Clark, Sofusa, Lymphatic Delivery
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news